3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Lymphoid
1
Dermatologic
1
Conditions
Mycosis Fungoides
1
Lymphoma, T-Cell, Cutaneous
1
Interventions
Cyclophosphamide
7
Biopsy
4
mogamulizumab
3
Specimen Handling
3
Peripheral Blood Stem Cell Transplantation
3
Etoposide
3
ruxolitinib
2
fludarabine phosphate
2
fludarabine
2
Whole-Body Irradiation
2
Vincristine
2
Tacrolimus
2
Prednisone
2
Nivolumab
2
Mycophenolic Acid
2
Magnetic Resonance Spectroscopy
2
Busulfan
2
tofacitinib
1
tazemetostat
1
talimogene laherparepvec
1
sodium-iodide symporter
1
pembrolizumab
1
hypericin
1
cemiplimab
1
belinostat
1
X-Rays
1
Vorinostat
1
Transplantation
1
Sirolimus
1
Radiotherapy
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Lymphoma, T-Cell, Cutaneous
×
hypericin
×
90 days
×
Clear all
NCT06470451
2026-04-03
FLASH2
Soligenix
Phase 3
Recruiting
80 enrolled